Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
Muhammad U. Rauf(The Royal Free Hospital), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Aviva Petrie(Eastman Dental Hospital), Simone Longhi(Azienda USL di Bologna), Claudio Rapezzi(University of Ferrara), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Lucia Venneri(MACOM (United States)), Dorota Roczenio(The Royal Free Hospital), Philip N. Hawkins(The Royal Free Hospital), Angelo Giuseppe Caponetti(Azienda USL di Bologna), Federico Perfetto(Azienda Ospedaliero-Universitaria Careggi), Mattia Zampieri(Azienda Ospedaliero-Universitaria Careggi), Alberto Ponziani(Azienda USL di Bologna), Brendan Wisniowski(The Royal Free Hospital), Christian Gagliardi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Janet A. Gilbertson(The Royal Free Hospital), Marianna Fontana(Amyloidosis Foundation), Antonella Accietto(Azienda USL di Bologna), Rishi Patel(Texas Tech University), Carol Whelan(The Royal Free Hospital), Joshua Bomsztyk(Roland Hill (United Kingdom)), Sriram Ravichandran(The Royal Free Hospital), Steven Law(The Royal Free Hospital), Maurizio Sguazzotti(Azienda USL di Bologna), Ashutosh Wechalekar(University College Hospital), Yousuf Razvi(The Royal Free Hospital), Aldostefano Porcari(Azienda Sanitaria Universitaria Integrata di Trieste), Elena Biagini, Alessia Argirò(University of Florence), Francesco Cappelli(National Institute of Optics), Neasa Starr(The Royal Free Hospital), David F. Hutt(Boston University), Giulia Saturi(University of Bologna), Ana Martinez–Naharro(Children's Cancer and Leukaemia Group), Alessandro Giovannetti(Azienda USL di Bologna), Paolo Massa(MACOM (United States)), Adam Ioannou(The Royal Free Hospital), Shameem Mahmood(The Royal Free Hospital), Matteo Serenelli(Cardiovascular Institute of the South)
Cited by 95
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k